Copy to clipboard 
Nanova Biomaterials introduces FiberFIX™ suture anchors and interference screws developed using patented nanocomposite technology. Our FiberFIX suture anchors and interference screws have demonstrated enhanced resistance to breakage/stripping during insertion and increased pull-out strength after-insertion, which reduces the failure rates during orthopedic operations. Real-time degradation tests on our FiberFIX devices have also indicated adequate mechanical stability for 3 months and no sign of self-catalytic degradation over 2 years of observation, which brings significant benefits in soft tissue fixation in sports medicine.
Biocomposite containing calcium phosphates, such as hydroxyapatite (HA), have the benefit of improving biocompatibility and osteoconductivity while reducing self-catalytic degradation. HA biocomposites have been used as bioresorbable implants in orthopedic operations, especially in sports medicine, for a long time. However, in current commercial biocomposite offerings, the calcium phosphate additives are generally in granules/particles form, which often makes the resulting composites weak and brittle.
FiberFIX represents a new generation of bioresorbable materials developed using breakthrough nanotechnology: biocomposites enhanced by specially modified single crystalline hydroxyapatite (HA) nanofibers. Nanofibers are about 100 nanometers in diameter and tens of micrometers in length with a strength close to its theoretical strength, several times stronger than stainless steel. Just like re-bar in concrete, our specially modified nanofiber can effectively strengthen the mechanical properties of the composites. Furthermore, with over-100 times greater surface area than traditional calcium phosphate particles, our modified nanofibers im-prove the acid buffering ability of FiberFIX devices, reduce acidic degradation of the composites, and minimize the body’s inflammatory response.
Since its creation, Nanova Biomaterials has been focusing on nanotechnology research and adopting such research to produce high-quality orthopedic and surgical devices. FiberFIX orthopedic devices made at Nanova Biomaterials’ Columbia, MO, facility are the culmination of years of research and scientific breakthroughs.
Nanova Biomaterials has obtained FDA 510(k) clearance for the FiberFIX Interference Screw (FDA K161174) and the FiberFIX Suture Anchor family (FDA K163672). With the launch of our FiberFIX devices in US and international markets in 2021, Nanova Biomaterials will contribute to the sports medicine arena with a revolutionary line of bioresorbable implants including high strength and improved biological properties.
Source: Nanova Biomaterials
Nanova Biomaterials introduces FiberFIX™ suture anchors and interference screws developed using patented nanocomposite technology. Our FiberFIX suture anchors and interference screws have demonstrated enhanced resistance to breakage/stripping during insertion and increased pull-out strength after-insertion, which reduces the failure rates during...
Nanova Biomaterials introduces FiberFIX™ suture anchors and interference screws developed using patented nanocomposite technology. Our FiberFIX suture anchors and interference screws have demonstrated enhanced resistance to breakage/stripping during insertion and increased pull-out strength after-insertion, which reduces the failure rates during orthopedic operations. Real-time degradation tests on our FiberFIX devices have also indicated adequate mechanical stability for 3 months and no sign of self-catalytic degradation over 2 years of observation, which brings significant benefits in soft tissue fixation in sports medicine.
Biocomposite containing calcium phosphates, such as hydroxyapatite (HA), have the benefit of improving biocompatibility and osteoconductivity while reducing self-catalytic degradation. HA biocomposites have been used as bioresorbable implants in orthopedic operations, especially in sports medicine, for a long time. However, in current commercial biocomposite offerings, the calcium phosphate additives are generally in granules/particles form, which often makes the resulting composites weak and brittle.
FiberFIX represents a new generation of bioresorbable materials developed using breakthrough nanotechnology: biocomposites enhanced by specially modified single crystalline hydroxyapatite (HA) nanofibers. Nanofibers are about 100 nanometers in diameter and tens of micrometers in length with a strength close to its theoretical strength, several times stronger than stainless steel. Just like re-bar in concrete, our specially modified nanofiber can effectively strengthen the mechanical properties of the composites. Furthermore, with over-100 times greater surface area than traditional calcium phosphate particles, our modified nanofibers im-prove the acid buffering ability of FiberFIX devices, reduce acidic degradation of the composites, and minimize the body’s inflammatory response.
Since its creation, Nanova Biomaterials has been focusing on nanotechnology research and adopting such research to produce high-quality orthopedic and surgical devices. FiberFIX orthopedic devices made at Nanova Biomaterials’ Columbia, MO, facility are the culmination of years of research and scientific breakthroughs.
Nanova Biomaterials has obtained FDA 510(k) clearance for the FiberFIX Interference Screw (FDA K161174) and the FiberFIX Suture Anchor family (FDA K163672). With the launch of our FiberFIX devices in US and international markets in 2021, Nanova Biomaterials will contribute to the sports medicine arena with a revolutionary line of bioresorbable implants including high strength and improved biological properties.
Source: Nanova Biomaterials
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
